Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 10;188(14):3728-3743.e20.
doi: 10.1016/j.cell.2025.04.020. Epub 2025 May 6.

m6A alters ribosome dynamics to initiate mRNA degradation

Affiliations

m6A alters ribosome dynamics to initiate mRNA degradation

Shino Murakami et al. Cell. .

Abstract

Degradation of mRNA containing N6-methyladenosine (m6A) is essential for cell growth, differentiation, and stress responses. Here, we show that m6A markedly alters ribosome dynamics and that these alterations mediate the degradation effect of m6A on mRNA. We find that m6A is a potent inducer of ribosome stalling, and these stalls lead to ribosome collisions that form a unique conformation unlike those seen in other contexts. We find that the degree of ribosome stalling correlates with m6A-mediated mRNA degradation, and increasing the persistence of collided ribosomes correlates with enhanced m6A-mediated mRNA degradation. Ribosome stalling and collision at m6A is followed by recruitment of YTHDF m6A reader proteins to promote mRNA degradation. We show that mechanisms that reduce ribosome stalling and collisions, such as translation suppression during stress, stabilize m6A-mRNAs and increase their abundance, enabling stress responses. Overall, our study reveals the ribosome as the initial m6A sensor for beginning m6A-mRNA degradation.

Keywords: N(6)-methyladenosine; TimeLapse-seq; adaptive response; amino acid depletion; m(6)A; mRNA decay; mRNA degradation; mRNA stability; ribosome collision; ribosome stall.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.R.J. is the co-founder, advisor, and/or has equity in Chimerna Therapeutics, 858 Therapeutics, and Lucerna Technologies.

References

    1. Poh HX, Mirza AH, Pickering BF, and Jaffrey SR (2022). Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA. PLOS Biology 20, e3001683. 10.1371/journal.pbio.3001683. - DOI - PMC - PubMed
    1. Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, Hershkovitz V, Peer E, Mor N, Manor YS, et al. (2015). m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science 347, 1002–1006. 10.1126/science.1261417. - DOI - PubMed
    1. Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, Patil DP, Kwak H, Lee JH, and Jaffrey SR (2019). m6A enhances the phase separation potential of mRNA. Nature 571, 424–428. 10.1038/s41586-019-1374-1. - DOI - PMC - PubMed
    1. Li G, Deng L, Huang N, Cui Z, Wu Q, Ma J, Pan Q, and Sun F (2021). m6A mRNA Methylation Regulates LKB1 to Promote Autophagy of Hepatoblastoma Cells through Upregulated Phosphorylation of AMPK. Genes 12, 1747. 10.3390/genes12111747. - DOI - PMC - PubMed
    1. Fry NJ, Law BA, Ilkayeva OR, Holley CL, and Mansfield KD (2017). N6-methyladenosine is required for the hypoxic stabilization of specific mRNAs. RNA 23, 1444–1455. 10.1261/rna.061044.117. - DOI - PMC - PubMed